Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 29, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 61 $2.44 $148.84
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 11

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,702

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 29, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 101 $2.44 $246.44
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 11

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,210

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 28, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 20 $2.51 $50.20
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 10

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,971

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 28, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 30 $2.51 $75.30
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 10

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,653

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 28, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 61 $2.51 $153.11
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 10

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,641

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 28, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 101 $2.51 $253.51
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 10

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,109

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 27, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 20 $2.41 $48.20
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 9

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,951

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 27, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 30 $2.41 $72.30
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 9

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,623

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 27, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 61 $2.41 $147.01
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 9

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,580

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 27, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 101 $2.41 $243.41
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 9

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,008

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 26, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 20 $2.53 $50.60
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 8

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,931

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 26, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 30 $2.53 $75.90
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 8

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,593

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 26, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 61 $2.53 $154.33
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 8

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,519

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 26, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 101 $2.53 $255.53
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 8

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,907

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 25, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 20 $2.62 $52.40
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 7

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,911

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 25, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 30 $2.62 $78.60
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 7

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,563

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 25, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 61 $2.62 $159.82
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 7

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,458

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 25, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 101 $2.62 $264.62
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 7

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,806

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 22, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 19 $2.73 $51.87
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 6

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,891

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 22, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 28 $2.73 $76.44
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 6

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,533

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 22, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 56 $2.73 $152.88
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 6

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,397

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 22, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 94 $2.73 $256.62
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 6

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,705

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 21, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 19 $2.75 $52.25
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 5

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,872

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 21, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 28 $2.75 $77.00
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 5

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,505

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 21, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 56 $2.75 $154.00
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 5

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,341

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 21, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 94 $2.75 $258.50
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 5

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,611

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 20, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 19 $2.74 $52.06
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 4

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,853

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 20, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 28 $2.74 $76.72
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 4

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,477

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 20, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 56 $2.74 $153.44
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 4

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,285

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 20, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 94 $2.74 $257.56
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 4

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,517

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 19, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 19 $2.69 $51.11
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 3

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,834

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 19, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 28 $2.69 $75.32
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 3

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,449

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 19, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 56 $2.69 $150.64
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 3

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,229

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 19, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 94 $2.69 $252.86
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 3

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,423

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 18, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 19 $2.63 $49.97
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 2

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,815

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 18, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 28 $2.63 $73.64
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 2

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,421

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 18, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 56 $2.63 $147.28
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 2

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,173

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 18, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 94 $2.63 $247.22
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 2

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,329

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 16, 2022 Filed May 6, 2022 21:05 UTC PurchaseCommon Stock 94 $2.71 $254.74
Disclosure

SEC source: 0001209191-22-027643 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,235

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 14, 2022 Filed May 6, 2022 21:09 UTC PurchaseCommon Stock 19 $2.71 $51.49
Disclosure

SEC source: 0001209191-22-027651 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,796

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 14, 2022 Filed May 6, 2022 21:08 UTC
Jones JamesDirector
PurchaseCommon Stock 28 $2.71 $75.88
Disclosure

SEC source: 0001209191-22-027649 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,393

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
April 14, 2022 Filed May 6, 2022 21:07 UTC PurchaseCommon Stock 56 $2.71 $151.76
Disclosure

SEC source: 0001209191-22-027646 · doc4.xml · nonDerivative · entry 1

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,117

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
March 20, 2022 Filed Apr 29, 2022 17:04 UTC
Herman James LVP and Chief Compliance Office
Tax withholdingCommon Stock 1,280 $2.74 $3,507.20
Disclosure

SEC source: 0001209191-22-026142 · doc4.xml · nonDerivative · entry 1

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,721

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 20, 2022 Filed Apr 29, 2022 16:58 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
Tax withholdingCommon Stock 37,205 $2.74 $101,941.70
Disclosure

SEC source: 0001209191-22-026135 · doc4.xml · nonDerivative · entry 2

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,753,358

F2 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 17, 2022 Filed Apr 29, 2022 17:11 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
OtherOptions (right to buy) · Derivative 5,000 $0.00 Strike: $3.22 $0.00
Disclosure

SEC source: 0001209191-22-026154 · doc4.xml · derivative · entry 2

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2031-03-17

F1 · kind: Mr. Cearnal passed away on March 17, 2022. All unvested equity awards forfeited upon death.

Read SEC document
March 17, 2022 Filed Apr 29, 2022 17:11 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
OtherCommon Stock 15,000 $2.74 $41,100.00
Disclosure

SEC source: 0001209191-22-026154 · doc4.xml · nonDerivative · entry 1

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,473

F1 · kind: Mr. Cearnal passed away on March 17, 2022. All unvested equity awards forfeited upon death.

Read SEC document
March 16, 2022 Filed Apr 29, 2022 17:09 UTC
Pavliv LeoSVP and Chief Development Off.
GrantOptions (right to buy) · Derivative 5,000 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001209191-22-026150 · doc4.xml · derivative · entry 1

Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-03-16

F1 · derivative.exercise_date: 100% vesting on March 16, 2026.

Read SEC document
March 16, 2022 Filed Apr 29, 2022 17:10 UTC GrantCommon Stock 1,000 $2.59 $2,590.00
Disclosure

SEC source: 0001209191-22-026152 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,777

F1 · shares: Restricted stock award will vest 100% on March 16, 2023.

Read SEC document
March 16, 2022 Filed Apr 29, 2022 17:08 UTC GrantCommon Stock 1,000 $2.59 $2,590.00
Disclosure

SEC source: 0001209191-22-026148 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,141

F1 · shares: Restricted stock award will vest 100% on March 16, 2023.

Read SEC document
March 16, 2022 Filed Apr 29, 2022 17:07 UTC
Jones JamesDirector
GrantCommon Stock 1,000 $2.59 $2,590.00
Disclosure

SEC source: 0001209191-22-026146 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,365

F1 · shares: Restricted stock award will vest 100% on March 16, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.